Formulation Development and Evaluation of Extended Release Dosage form of Cilostazol for Treathment of Intermittent Chau

Enregistré dans:

Détails bibliographiques
Auteur principal:	Desai Chirag T.
Format:	Thèse Livre
Langue:	anglais
Publié:	Mumbai NMIMS-SPPSPTM 2015
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELESES DOSAGE FORM OF CLIOSTAZOL FOR TREATMENT OF INTERMITTENT CLAUD
par: DESAI CHIRAG

FORMULATION AND EVALUATION OF EXTENDED RELEASE SOLID ORAL DOSAGE FORM OF DRUG X
par: DESAI RAVI

FORMULATION DEVELOPMENT AND EVALUATION OF AN EXTENDED RELEASE DOSAGE FOR MOF AN ANTIHYPERTENSIVE AGENTS
par: PATEL HITESH

Development and Evaluation of Extended Release Dosage Forms of Anti-Diabetic Drugs
par: Srivastav Monika
Publié: (2012)

PREPARATION AND EVALUATION OF LORNOXICAM EXTENDED RELEASE FORMULATION
par: NAVANDAR SHRADDHA

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE ANTI-ANGINAL TABLETS
par: CHOKSHI DWEEP

FORMULATION DEVELOPMENT AND EVALUATION OF BUPROPION HYDROCHLORIDE EXTENDED RELEASE TABLETS
par: PATADE PRAGATI

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE CAPSULE OF TOLTERODINE TARTRATE
par: PATEL JAIMINKUMAR

DEVELOPMENT & FORMULATION OF?.DOSAGE FORMS
par: HARDEE GREGORY E (ED.)

FORMULATION AND DEVELOPMENT OF ANTICONVULSANT EXTENDED RELEASE TABLETS
par: PATEL KARISHMA

FORMULATION, DEVELOPMENT AND IN-VITRO EVALUATION OF EXTENDED RELEASE CAPSULES BY WURSTER TECHNOLOGY
par: DUDANI KEYUR

FORMULATION DEVELOPMENT AND EVALUATION OF AN EXTENDED RELEASE GASTRORETENTIVE TABLETS FOR AN ANTIHYPERTENSIVE DRUG
par: JAIN ABHISHEK

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF AN ANTI-HYPERTENSIVE DRUG
par: KOTHARI HARSH

FORMULATION AND EVALUATION OF ISOSORBIDE-5- MONONITRATE EXTENDED RELEASE TABLET
par: PATIL GAURAV

DEVELOPMENT AND EVALUATION OF ONCE A DAILY ORAL DOSAGE FORM OF LAMOTRIGINE
par: SHAH CHIRAG

DEVELOPMENT AND FORMULATION OF VETERNIARY DOSAGE FORMS
par: HARDEE GREGORY E [E], BAGGOT J DESMOND [E]
Publié: (1998)

FORMULATION AND EVALUATION OF SODIUM VALPROATE AND VALPROIC ACID EXTENDED RELEASE TABLET
par: DAFTARY ADITI

FORMULATION AND EVALUATION OF EXTENDED RELEASE MATRIX TABLET OF HIGHLY SOLUBLE DRUG
par: DAFTARDAR SALONI

TO ENHANCE THE SOLUBILITY AND DEVELOP THE LIPOSOMES OF CILOSTAZOL
par: JAGTAP HRISHIKESH

PREPARATION AND EVALUATION OF FELODIPINE EXTENDED RELEASE CAPSULES
par: VIJAYAN VIVEK

FORMULATION AND EVALUATION OF NEW OPHTHALMIC DOSAGE FORM OF GATIFLOXACIN
par: PALKAR MAYURESH

CONTROLLED RELEASE DOSAGE FORM DESIGN
par: CHERNG -JU KIM
Publié: (2000)

FORMULATION DEVELOPMENT AND EVALUATION OF DELAYED RELEASE TABLET FORMULATION
par: SHAH SNEHAL

FORMULATION DEVELOPMENT AND EVALUATION OF FIXED DOSE COMBINATION FOR HYPERTENSION
par: DESAI CHIRAG

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF HIGHLY WATER SOLUBLE DRUG X
par: SHAHI JAYA

FORMULATION PROCESS DEVELOPMENT AND EVALUATION OF FILM COATED ANTIEPILEPTIC EXTENDED RELEASE MATRIX TABLET
par: SHAH BHAUMIK

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE MULTIPARTICULATE DRUG DELIVERY SYSTEMS CONTAINING AN ANTIADRE
par: RUSTAGI DOLLY

Science of intermittent fasting
par: Vanderschelden, M
Publié: (2019)

FORMULATION AND EVALUATION OF FELODIPINE EXTENDED RELEASE TABLETS BY HOT MELT GRANULATION METHOD
par: PRIYADARSHI JIGAR

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS CONTAINING ANTI-PSYCHOTIC AGENT DRUG 'X'
par: DUBEY POOJA

FORMULATION DEVELOPMENT AND EVALUATION OF A BILAYER EXTENDED RELEASE TABLET CONTAINING ANALGESIC AND ANTIPYRETIC AGENTS
par: PAWAR VIKAS

FORMULATION DEVELOPMENT AND EVALUATION OF XYZ/ABC EXTENDED RELEASE BILAYER TABLETS CONTAINING ANTIHYPERTENSIVE AGENTS
par: HELGAR KISHORE

FORMULATION AND DEVELOPMENT OF EXTENDED RELEASE TABLETS OF A B-BLOCKING AGENT
par: RAKSHIT PUSHPITA

FORMULATION AND DEVELOPMENT OF ANTI-PARKINSON DRUG-X EXTENDED RELEASE TABLETS
par: PATEL KRUTI

FORMULATION DEVELOPMENT AND EVALUATION OF ORAL SOLID DOSAGE FORM CONTAINING AN ANTISYCHOTIC AGENT
par: MOHITE ASHISH

DEVELOPMENT AND EVALUATION OF ABT 01 EXTENDED RELEASE TABLET AS PER USP
par: DAVE SHIVAM

FORMULATION AND DEVELOPMENT OF LIQUID DOSAGE FORM LEVOFLOXACIN HEMIHYDRATE
par: PIYUSH PATEL

FORMULATION AND EVALUATION OF PROLIPOSOMES OF BENDAMUSTINE HYDROCHLORIDE INTO A POWDER DOSAGE FORM
par: YADAV INDU

FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF AN ANTIDIABETIC DRUG A
par: DESAI NEEL

FORMULATION AND EVALUATION OF BILAYERED TABLET OF TRIMETAZIDINE DIHYDROCHLORIDE 35mg EXTENDED RELEASE AND METOPROLOL TAR
par: PATIL NISHA